Correlation Between Salient Alternative and Health Biotchnology
Can any of the company-specific risk be diversified away by investing in both Salient Alternative and Health Biotchnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salient Alternative and Health Biotchnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salient Alternative Beta and Health Biotchnology Portfolio, you can compare the effects of market volatilities on Salient Alternative and Health Biotchnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salient Alternative with a short position of Health Biotchnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salient Alternative and Health Biotchnology.
Diversification Opportunities for Salient Alternative and Health Biotchnology
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Salient and Health is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Salient Alternative Beta and Health Biotchnology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Biotchnology and Salient Alternative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salient Alternative Beta are associated (or correlated) with Health Biotchnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Biotchnology has no effect on the direction of Salient Alternative i.e., Salient Alternative and Health Biotchnology go up and down completely randomly.
Pair Corralation between Salient Alternative and Health Biotchnology
Assuming the 90 days horizon Salient Alternative Beta is expected to generate 0.84 times more return on investment than Health Biotchnology. However, Salient Alternative Beta is 1.2 times less risky than Health Biotchnology. It trades about 0.07 of its potential returns per unit of risk. Health Biotchnology Portfolio is currently generating about 0.03 per unit of risk. If you would invest 941.00 in Salient Alternative Beta on November 30, 2024 and sell it today you would earn a total of 229.00 from holding Salient Alternative Beta or generate 24.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Salient Alternative Beta vs. Health Biotchnology Portfolio
Performance |
Timeline |
Salient Alternative Beta |
Health Biotchnology |
Salient Alternative and Health Biotchnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Salient Alternative and Health Biotchnology
The main advantage of trading using opposite Salient Alternative and Health Biotchnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salient Alternative position performs unexpectedly, Health Biotchnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will offset losses from the drop in Health Biotchnology's long position.Salient Alternative vs. Investec Global Franchise | Salient Alternative vs. Dreyfusstandish Global Fixed | Salient Alternative vs. Wisdomtree Siegel Global | Salient Alternative vs. Doubleline Global Bond |
Health Biotchnology vs. Nuveen North Carolina | Health Biotchnology vs. Federated Government Income | Health Biotchnology vs. Arrow Managed Futures | Health Biotchnology vs. Rbc Emerging Markets |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |